These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 25700579)
21. Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials. Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T Blood Press; 2014 Jun; 23(3):135-7. PubMed ID: 24842262 [No Abstract] [Full Text] [Related]
22. Renal sympathetic denervation in the treatment of resistant hypertension. Sánchez-Álvarez C; González-Vélez M; Stilp E; Ward C; Mena-Hurtado C Yale J Biol Med; 2014 Dec; 87(4):527-35. PubMed ID: 25506285 [TBL] [Abstract][Full Text] [Related]
23. Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges. Persu A; Kjeldsen S; Staessen JA; Azizi M Curr Hypertens Rep; 2016 Jan; 18(1):6. PubMed ID: 26739586 [TBL] [Abstract][Full Text] [Related]
30. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go? Briasoulis A; Bakris G Can J Cardiol; 2015 May; 31(5):642-8. PubMed ID: 25828371 [TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. Geisler BP; Egan BM; Cohen JT; Garner AM; Akehurst RL; Esler MD; Pietzsch JB J Am Coll Cardiol; 2012 Oct; 60(14):1271-7. PubMed ID: 22981547 [TBL] [Abstract][Full Text] [Related]
32. Renal denervation in the management of resistant hypertension: current evidence and perspectives. Jin Y; Persu A; Staessen JA Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701 [TBL] [Abstract][Full Text] [Related]
33. Renal denervation in moderate treatment-resistant hypertension. Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901 [TBL] [Abstract][Full Text] [Related]
34. Renal denervation for the treatment of resistant hypertension: review and clinical perspective. Iliescu R; Lohmeier TE; Tudorancea I; Laffin L; Bakris GL Am J Physiol Renal Physiol; 2015 Oct; 309(7):F583-94. PubMed ID: 26224718 [TBL] [Abstract][Full Text] [Related]
35. Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving? Al-Fakhouri A; Efeovbokhan N; Nakhla R; Khouzam RN Rev Port Cardiol; 2016 Oct; 35(10):531-8. PubMed ID: 27614724 [TBL] [Abstract][Full Text] [Related]
36. Percutaneous renal sympathetic denervation: 2013 and beyond. Froeschl M; Hadziomerovic A; Ruzicka M Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191 [TBL] [Abstract][Full Text] [Related]
37. Renal sympathetic denervation for resistant hypertension. Froeschl M; Hadziomerovic A; Ruzicka M Can J Cardiol; 2013 May; 29(5):636-8. PubMed ID: 23541665 [TBL] [Abstract][Full Text] [Related]
38. The future of renal denervation. Esler M; Guo L Auton Neurosci; 2017 May; 204():131-138. PubMed ID: 27546827 [TBL] [Abstract][Full Text] [Related]
39. [Renal denervation a treatment for resistant hypertension: a French experience]. Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC; Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849 [TBL] [Abstract][Full Text] [Related]
40. Renal denervation: unde venis et quo vadis? Nähle CP; Düsing R; Schild H Rofo; 2015 Apr; 187(4):237-47. PubMed ID: 25629384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]